There is evidence that Beclin-1 has a positive prognostic effect in uveal melanoma, with higher immunohistochemistry levels of the protein being associated with better outcomes in terms of metastasis risk and overall survival (Broggi et al. 2020). The gene discussed is BECN1; the disease is uveal melanoma.